research use only

MK-0752 Secretase inhibitor

Cat.No.S2660

MK-0752 is a moderately potent γ-secretase inhibitor, which reduces Aβ40 production with IC50 of 5 nM. Phase 1/2.
Jump to

Quality Control

Batch: Purity: 99.21%
99.21

Solubility

In vitro
Batch:

DMSO : 89 mg/mL (200.94 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 442.9 Formula

C21H21ClF2O4S

Storage (From the date of receipt)
CAS No. 471905-41-6 Download SDF Storage of Stock Solutions

Synonyms N/A SMILES C1CC(CCC1CCC(=O)O)(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Features
A moderately potent γ-secretase inhibitor.
Targets/IC50/Ki
Aβ
(in human SH-SY5Y cells)
5 nM
In vitro
MK-0752 is identified as a moderately potent γ-secretase inhibitor, which reduces Aβ40 in a dose-dependent manner with an IC50 of 5 nM in human SH-SY5Y cells. In vitro, this compound blocks Notch-intracellular domain (ICD) cleavage and its subsequent nuclear translocation.
In vivo
MK-0752 (240 mg/kg) reduces the generation of newly produced Aβ with 90% decrease of AUV in the brain of rhesus monkeys. In addition, this compound treatment increases levels of Aβ 1-14, Aβ 1-15, and Aβ 1-16 , while decreases levels of Aβ 1-17. In guinea-pigs, oral administration of this chemical (10 mg/kg -30 mg/kg) results in the dose-dependent reduction of Aβ40 in plasma, brain and cerebrospinal fluid (CSF) with IC50 of 440 nM in brain.
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2015-10-14)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01098344 COMPLETED
Pancreatic Cancer
Cancer Research UK
2010-04 PHASE1
NCT01295632 COMPLETED
Advanced Cancer
Merck Sharp & Dohme LLC
2011-02 PHASE1
NCT01243762 TERMINATED
Neoplasms Malignant
Merck Sharp & Dohme LLC
2010-11-22 PHASE1
NCT00756717 COMPLETED
Breast Cancer
Loyola University
2008-02-14 PHASE4
NCT00106145 COMPLETED
Advanced Breast Cancer; Other Solid Tumors
Merck Sharp & Dohme LLC
2005-04 PHASE1
NCT01295632 Completed
Advanced Cancer
Merck Sharp & Dohme LLC
2011-02 Phase 1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
Do you have the half-life information for it when used in cell culture?

Answer:
Its half-life in patients is about 15 hours, but in different cell culture it might be various, and we generally recommend replenishing with fresh drug every 24-48 hours.